I just got feedback from a health care focused hedge fund who said the M&A environment is certainly going to be much more favorable (cheaper capital, more accommodating FTC, and valuations being favorable). He would be surprised if we didn’t see deal flow pick up in the short term, likely with a few deals announced prior to year-end and Q1 being active.
Market Data 
Markets 
AI
